Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study)

Gut microbiota is believed to be a major determinant of health outcomes. We hypothesised that a novel oral microbiome formula (SIM01) can reduce the risk of adverse health outcomes in at-risk subjects during the coronavirus disease 2019 (COVID-19) pandemic. In this single-centre, double-blind, rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Martin C. S., Zhang, Lin, Ching, Jessica Y. L., Mak, Joyce W. Y., Huang, Junjie, Wang, Shilan, Mok, Chris K. P., Wong, Angie, Chiu, Oi-Lee, Fung, Yee-Ting, Cheong, Pui-Kuan, Tun, Hein-Min, Ng, Siew C., Chan, Francis K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143994/
https://www.ncbi.nlm.nih.gov/pubmed/37111201
http://dx.doi.org/10.3390/nu15081982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143994/
https://www.ncbi.nlm.nih.gov/pubmed/37111201
http://dx.doi.org/10.3390/nu15081982

Ejemplares similares